Explore › Outcome › ACE inhibitor
Outcome

ACE inhibitor

Also known as: ACE INHIB ACE Inhibitor ACE Inhibitors ACE inhibitor ACE inhibitor product ACE inhibitor, NOS ANGIOTENSIN CONVERTING ENZYME ANTAG ANTAG ANGIOTENSIN CONVERTING ENZYME ANTAG KININASE II Angiotensin Converting Enzyme Antagonists Angiotensin Converting Enzyme Inhibitor Angiotensin Converting Enzyme Inhibitors +38 more
3 findings 1 paper 3 related entities View in graph →

Related entities

interventions
ACE Inhibitors1
conditions
Congestive heart failure with right heart failure1
studys
PMC80096951

Findings (27)

None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →
None
null

Commercially insured patients with intellectual/developmental disabilities and heart failure had a lower but statistically insignificant difference in pharmacy claims for ACE inhibitor/ARB therapy com

Effect: null; adjusted OR 0.87; CI: 95% CI = 0.76-1.003

Size: adjusted OR 0.87 CI: 95% CI = 0.76-1.003
PMC8009695
Finding details → · Paper → · Graph →

Papers (1)